188 related articles for article (PubMed ID: 24969973)
21. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma.
Kamyab-Hesari K; Seirafi H; Naraghi ZS; Shahshahani MM; Rahbar Z; Damavandi MR; Naraghi MM; Rezvani M; Aghazadeh N
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):250-3. PubMed ID: 22989368
[TBL] [Abstract][Full Text] [Related]
22. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
23. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
[TBL] [Abstract][Full Text] [Related]
24. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
25. Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes.
Camela E; Ilut Anca P; Lallas K; Papageorgiou C; Manoli SM; Gkentsidi T; Eftychidou P; Liopyris K; Sgouros D; Apalla Z; Lallas A
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837550
[No Abstract] [Full Text] [Related]
26. The prognostic value of CXCR4, α-SMA and WASL in upper lip basal cell carcinomas.
Sălan AI; Mărăşescu PC; Camen A; Ciucă EM; Matei M; Florescu AM; Pădureanu V; Mărgăritescu C
Rom J Morphol Embryol; 2018; 59(3):839-849. PubMed ID: 30534824
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
28. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of biopsy sampling for subtyping basal cell carcinoma.
Haws AL; Rojano R; Tahan SR; Phung TL
J Am Acad Dermatol; 2012 Jan; 66(1):106-11. PubMed ID: 21798620
[TBL] [Abstract][Full Text] [Related]
30. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy.
Longo C; Lallas A; Kyrgidis A; Rabinovitz H; Moscarella E; Ciardo S; Zalaudek I; Oliviero M; Losi A; Gonzalez S; Guitera P; Piana S; Argenziano G; Pellacani G
J Am Acad Dermatol; 2014 Oct; 71(4):716-724.e1. PubMed ID: 24928707
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
Vidal D; Matías-Guiu X; Alomar A
Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
[TBL] [Abstract][Full Text] [Related]
32. Histological subtypes of periocular basal cell carcinoma.
Wu A; Sun MT; Huilgol SC; Madge S; Selva D
Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
[TBL] [Abstract][Full Text] [Related]
33. Twist1 in tumor cells and α-smooth muscle actin in stromal cells are possible biomarkers for metastatic giant basal cell carcinoma.
Motegi S; Yamada K; Ishikawa O
J Dermatol; 2013 Aug; 40(8):661-3. PubMed ID: 23683049
[TBL] [Abstract][Full Text] [Related]
34. Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy Outcome.
Mørk E; Mjønes P; Foss OA; Bachmann IM; Christensen E
J Histochem Cytochem; 2023 Mar; 71(3):111-120. PubMed ID: 36961748
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients.
Chang JM; Gao XM
Chin Med J (Engl); 2013 Jan; 126(2):211-4. PubMed ID: 23324265
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin.
Ishida M; Kushima R; Okabe H
J Cutan Pathol; 2008 Oct; 35(10):926-30. PubMed ID: 18537863
[TBL] [Abstract][Full Text] [Related]
38. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
40. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
